Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment
Background & Aims Based on platelets and liver stiffness measurements, the Baveno VI
criteria (B6C), the expanded B6C (EB6C), and the ANTICIPATE score can be used to rule …
criteria (B6C), the expanded B6C (EB6C), and the ANTICIPATE score can be used to rule …
The Baveno VI criteria for predicting esophageal varices: validation in real life practice
M Sousa, S Sousa Fernandes, L Proença… - Revista Española de …, 2017 - SciELO Espana
Background and aims: According to the Baveno VI consensus, patients with liver stiffness<
20 kPa and a platelet count> 150,000 ul have very low risk of clinically significant varices …
20 kPa and a platelet count> 150,000 ul have very low risk of clinically significant varices …
Non-invasive prediction of esophageal varices by stiffness and platelet in non-alcoholic fatty liver disease cirrhosis
S Petta, G Sebastiani, E Bugianesi, M Viganò… - Journal of …, 2018 - Elsevier
Background & Aims Baveno VI and expanded Baveno VI criteria can avoid the need for
esophagogastroduodenoscopy (EGD) to screen for varices needing treatment (VNT) in a …
esophagogastroduodenoscopy (EGD) to screen for varices needing treatment (VNT) in a …
[HTML][HTML] Screening for esophageal varices in cirrhotic patients–non-invasive methods
ÂZ Mattos, FC Schacher, GJ Neto, AA Mattos - Annals of Hepatology, 2019 - Elsevier
Variceal bleeding is a dramatic complication of cirrhosis. Primary prophylaxis against
variceal bleeding is indicated for patients with high-risk varices. In order for these patients to …
variceal bleeding is indicated for patients with high-risk varices. In order for these patients to …
[HTML][HTML] Liver stiffness and serum markers for excluding high-risk varices in patients who do not meet Baveno VI criteria
H Zhou, J Long, H Hu, CY Tian… - World Journal of …, 2019 - ncbi.nlm.nih.gov
BACKGROUND The Baveno VI criteria for predicting esophageal varices, ie., liver stiffness
measurement (LSM)< 20 kPa and platelet (PLT) count> 150× 10 9/L, identify patients who …
measurement (LSM)< 20 kPa and platelet (PLT) count> 150× 10 9/L, identify patients who …
Liver stiffness and platelet count for identifying patients with compensated liver disease at low risk of variceal bleeding
A Marot, E Trépo, C Doerig, A Schoepfer… - Liver …, 2017 - Wiley Online Library
Abstract Background & Aims The 2015 Baveno VI guidelines recommend against
performing upper gastrointestinal endoscopy in patients with compensated cirrhosis who …
performing upper gastrointestinal endoscopy in patients with compensated cirrhosis who …
Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis
L Zhao, T Wang, C Guo, L Zhou, P Han, C Wang… - Hepatology …, 2022 - Springer
Abstract Background The Baveno VI criteria (B6C) have been recommended to screen high-
risk varices (HRV) in patients with liver cirrhosis to avoid the use of …
risk varices (HRV) in patients with liver cirrhosis to avoid the use of …
Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices
JB Maurice, E Brodkin, F Arnold, A Navaratnam… - Journal of …, 2016 - Elsevier
Background & Aims The Baveno VI guidelines propose that cirrhotic patients with a liver
stiffness measurement (LSM)< 20 kPa and a platelet count> 150,000/μl can avoid screening …
stiffness measurement (LSM)< 20 kPa and a platelet count> 150,000/μl can avoid screening …
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease
Background & Aims Recently, Baveno VI guidelines suggested that
esophagogastroduodenoscopy (EGD) can be avoided in patients with compensated …
esophagogastroduodenoscopy (EGD) can be avoided in patients with compensated …
[HTML][HTML] Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study
AA Protopapas, T Mylopoulou… - Annals of …, 2020 - ncbi.nlm.nih.gov
Methods: We prospectively enrolled patients with advanced liver disease (defined as LSM>
12 kPa) and evaluated them according to the Baveno VI criteria. Exclusion criteria were …
12 kPa) and evaluated them according to the Baveno VI criteria. Exclusion criteria were …